IRDiRC

The International Rare Diseases Research Consortium (IRDiRC) launched in April 2011 at the initiative of the European Commission and the National Institutes of Health (USA) to foster international collaboration in rare disease research.

IRDiRC

The IRDiRC brings together researchers and organisations investing in rare disease research to achieve two main objectives: deliver 200 new therapies for rare diseases and the means to diagnose most rare diseases by the year 2020.

EURORDIS is actively involved in the IRDiRC Executive Committee, Scientific Committees and Working Groups. EURORDIS provides inputs and support to its IRDiRC representatives, contributing to key policy documents by submitting policy proposals and amendments that aim to ensure the presence of rare disease patients in the decision-making process of the IRDiRC.

Page created: 23/07/2013
Page last updated: 06/11/2014
 
 
The voice of rare disease patients in EuropeEURORDIS The international voice of people living with rare diseases, Rare Diseases International is a EURORDIS initiativeRare Disease International Bringing together patients, families and experts to share experiences in a moderated multilanguage forum, RareConnect is a EURORDIS initiative RareConnect An international awareness raising campaign taking place on the last day of February each year, Rare Disease Day is a EURORDIS initiativeRare Disease Day Join the largest gathering of rare disease stakeholders across Europe, at the biennial European Conference on Rare Diseases and Orphan Products. ECRD is a EURORDIS initiativeEuropean Conference on Rare Diseases